Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases

Immunological Reviews

Volumn 245, Issue 1, 2012, Pages 164-176

  Macia, Laurence ^a   Thorburn, Alison N ^a   Binge, Lauren C ^a   Marino, Eliana ^a   Rogers, Kate E ^a   Maslowski, Kendle M ^b   Vieira, Angélica T ^c   Kranich, Jan ^d   Mackay, Charles R ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Epithelium; GPR43; Microbiota; Short chain fatty acids

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; B7 ANTIGEN; BETA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD86 ANTIGEN; CRYOPYRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 43; GAMMA INTERFERON; HEAT SHOCK PROTEIN 25; HEAT SHOCK PROTEIN 72; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 33; INTERLEUKIN 4; MUCIN; MUCIN 13; MUCIN 2; PREBIOTIC AGENT; PROBIOTIC AGENT; RECOMBINANT P40 PROTEIN; RECOMBINANT PROTEIN; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; VSL3;

APOPTOSIS; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL TRANSLOCATION; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM LONGUM; CELL MATURATION; CELL MIGRATION; CESAREAN SECTION; CLOSTRIDIUM; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DIET; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG USE; DYSBIOSIS; ENTERITIS; ENTEROCHROMAFFIN CELL; EPITHELIAL INTEGRITY; EPITHELIUM; FIRMICUTES; FOOD ALLERGY; GOBLET CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE CELL; INTESTINE FLORA; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; LAMINA PROPRIA; MACROPHAGE; MAST CELL; MESENTERY LYMPH NODE; MUCOSAL IMMUNITY; NEUTROPHIL; NONHUMAN; ORGANISMAL INTERACTION; PANETH CELL; PERITONEUM CELL; PERSONAL HYGIENE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; RHINITIS; TH17 CELL; ULCERATIVE COLITIS; UPREGULATION; VAGINAL DELIVERY;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; DIET; DIETARY SUPPLEMENTS; FATTY ACIDS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNE TOLERANCE; INFLAMMATION; INTESTINAL MUCOSA; RECEPTORS, G-PROTEIN-COUPLED;

EID: 83655193494     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2011.01080.x     Document Type: Review

References (119)

1. De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from europe and rural africa. Proc Natl Acad Sci USA 2010;107:14691-14696.
2. Muegge BD, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011;332:970-974.
3. Faith JJ, McNulty MP, Rey FE, Gordon JI. Predicting a human gut microbiota response to diet in gnotobiotic mice. Science 2011;333:101-104.
4. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol 2011;12:5-9.
5. Oh DY, et al. Gpr120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-698.
6. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011;17:557-566.
7. Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011;242:205-219.
8. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008;57:2555-2562.
9. Venn BJ, Mann JI. Cereal grains, legumes and diabetes. Eur J Clin Nutr 2004; 58:1443-1461.
10. Lim CC, Ferguson LR, Tannock GW. Dietary fibres as "prebiotics": implications for colorectal cancer. Mol Nutr Food Res 2005; 49:609-619.
11. Galvez J, Rodriguez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005; 49:601-608.
12. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011; 476:393-394.
13. Shaheen SO. Commentary: paracetamol and asthma-lessons from the antibiotic hypothesis? Int J Epidemiol 2011;40:667-669.
14. Strachan D. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000;55(Suppl.):S2-S10.
15. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Ped Gastroenterol Nutr 1999;28:19-25.
16. Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004;53:1388-1389.
17. Caporaso JG, et al. Moving pictures of the human microbiome. Genome Biol 2011;12:R50.
18. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JL. Human nutrition, the gut microbiome and the immune system. Nature 2011;474:327-336.
19. Arumugam M, et al. Enterotypes of the human gut microbiome. Nature 2011; 473:174-180.
20. Wu GD, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-108.
21. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
22. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261.
23. Sellon RK, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-5231.
24. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-13785.
25. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJO. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006;44:4136-4141.
26. Manichanh C, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-211.
27. Maslowski KM, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor gpr43. Nature 2009;461:1282-1286.
28. Ivanov II, et al. Specific microbiota direct the differentiation of il-17-producing t-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4:337-349.
29. Elinav E, et al. Nlrp6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011;145:745-757.
30. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010;105:2687-2692.
31. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60:49-54.
32. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmunity 2010;34:J168-J177.
33. Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in nod mice. Diabetologia 2010; 53:741-748.
34. Wen L, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008;455:1109-1113.
35. Kim HS, et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007;27:321-333.
36. Vijay-Kumar M, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010;328:228-231.
37. Alam C, et al. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (nod) mice. Diabetologia 2011;54:1398-1406.
38. Chervonsky AV. Influence of microbial environment on autoimmunity. Nat Immunol 2010;11:28-35.
39. Nieuwenhuis EE, et al. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 2009; 119:1241-1250.
40. Petnicki-Ocwieja T, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 2009;106:15813-15818.
41. Ishikawa H, et al. Effect of intestinal microbiota on the induction of regulatory cd25+ cd4+ t cells. Clin Exp Immunol 2008;153:127-135.
42. Ivanov II, et al. Induction of intestinal th17 cells by segmented filamentous bacteria. Cell 2009;139:485-498.
43. Zaph C, et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 2008;205:2191-2198.
44. Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010;59:2237-2246.
45. Alam C, Valkonen S, Ohls S, Tornqvist K, Hanninen A. Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal b lymphocytes in non-obese diabetic mice. Diabetologia 2010;53:346-355.
46. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 2011;108(Suppl.):4607-4614.
47. Mangialaio S, Ji H, Korganow A-S, Kouskoff V, Benoist C, Mathis D. The arthritogenic t cell receptor and its ligand in a model of spontaneous arthritis. Arthritis Rheum 1999;42:2517-2523.
48. Korganow A-S, et al. From systemic t cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-461.
49. Eerola E, et al. Intestinal flora in early rheumatoid arthritis. Rheumatology 1994;33:1030-1038.
50. Vaahtuvuo J, Munukka E, Korkeamnki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008;35:1500-1505.
51. Allan K, Devereux G. Diet and asthma: nutrition implications from prevention to treatment. J Am Dietetic Assoc 2011; 111:258-268.
52. McLoughlin RM, Mills KHG. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allerg Clin Immunol 2011; 127:1097-1107.
53. Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin d: interrelated exposures influencing allergy, asthma, and obesity? J Allerg Clin Immunol 2011;127:1087-1094.
54. Devereux G, et al. Low maternal vitamin e intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006;174:499-507.
55. Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. J Allerg Clin Immunol 2010;125(Suppl.):S81-S94.
56. Moffatt MF, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010;363:1211-1221.
57. Chen G, et al. Spdef is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest 2009; 119:2914-2924.
58. Chen G, et al. Foxa2 programs Th2 cell-mediated innate immunity in the developing lung. J Immunol 2010;184:6133-6141.
59. Holgate ST, Roberts G, Arshad HS, Howarth PH, Davies DE. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc 2009;6:655-659.
60. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;120:1233-1244.
61. Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LAS. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol 2009;123:146-152.e148.
62. Wark PAB, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-947.
63. Murray CS. Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allerg Clin Immunol 2008;8:77-81.
64. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
65. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-1227.
66. Monira S, et al. Short-chain fatty acids and commensal microbiota in the faeces of severely malnourished children with cholera rehydrated with three different carbohydrates. Eur J Clin Nutr 2010;64:1116-1124.
67. Huda-Faujan N, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 2010;4:53-58.
68. Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 2011;32:256-264.
69. Balda MS, Matter K. Tight junctions at a glance. J Cell Sci 2008;121:3677-3682.
70. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein zo-1 in dextran sulfate sodium induced colitis. J Surg Res 2007; 140:12-19.
71. Cani PD, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving glp-2-driven improvement of gut permeability. Gut 2009;58:1091-1103.
72. Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastroenterol Surg 2010;2:61-69.
73. Wilson CL, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286:113-117.
74. Salzman NH. Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces. Gut microbes 2010; 1:401-406.
75. Salzman NH, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76-83.
76. Nuding S, Fellermann K, Wehkamp J, Stange EF. Reduced mucosal antimicrobial activity in crohn's disease of the colon. Gut 2007;56:1240-1247.
77. Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the muc2 mucin, whereas the outer layer is a legislator of host'äìmicrobial interactions. Proc Natl Acad Sci USA 2011;108(Suppl.):4659-4665.
78. Petersson J, et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011;300:G327-G333.
79. Van der Sluis M, et al. Muc2-deficient mice spontaneously develop colitis, indicating that muc2 is critical for colonic protection. Gastroenterol 2006;131:117-129.
80. Sheng YH, et al. The muc13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut 2011.
81. Amar J, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011;3:559-572.
82. Barcelo A, Claustre J, Moro F, Chayvialle JA, Cuber JC, Plaisancie P. Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 2000; 46:218-224.
83. Gaudier E, et al. Butyrate specifically modulates muc gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol 2004;287:G1168-G1174.
84. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241.
85. Sikora A, Grzesiuk E. Heat shock response in gastrointestinal tract. J Physiol Pharmacol 2007;58(Suppl.):43-62.
86. Arvans DL, et al. Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. AM J Physiol Gastrointest Liver Physiol 2005;288:G696-G704.
87. Ren H, Musch MW, Kojima K, Boone D, Ma A, Chang EB. Short-chain fatty acids induce intestinal epithelial heat shock protein 25 expression in rats and iec 18 cells. Gastroenterology 2001;121:631-639.
88. Ott SJ, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685-693.
89. Fleming LL, Floch MH. Digestion and absorption of fiber carbohydrate in the colon. Am J Gastroeneterol 1986;81:507-511.
90. Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP. Identification and characterization of a monocarboxylate transporter (mct1) in pig and human colon: its potential to transport l-lactate as well as butyrate. J Physiol 1998;513:719-732.
91. Thibault R, et al. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 2007; 133:1916-1927.
92. Suzuki T, Yoshida S, Hara H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br J Nutr 2008;100:297-305.
93. Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-547.
94. Tedelind S, Westberg F, Kjerruld M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007;13:2826-2832.
95. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832.
96. Ogura Y, et al. A frameshift mutation in nod2 associated with susceptibility to crohn's disease. Nature 2001;411:603-606.
97. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The nlrp3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-391.
98. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the nalp3 inflammasome. Nature 2006;440:237-241.
99. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by nod1 enhances systemic innate immunity. Nat Med 2010;16:228-231.
100. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001;414:555-558.
101. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005;122:107-118.
102. Round JL, et al. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011;332:974-977.
103. Atarashi K, et al. Induction of colonic regulatory t cells by indigenous clostridium species. Science 2011;331:337-341.
104. Gaboriau-Routhiau V, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper t cell responses. Immunity 2009;31:677-689.
105. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004;12:562-568.
106. Garcia-Lafuente A, Antolin M, Guarner F, Crespo E, Malagelada JR. Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut 2001;48:503-507.
107. Madsen K, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121:580-591.
108. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive escherichia coli (eiec). Gut 2003;52:988-997.
109. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. Molecular mechanisms underlying the probiotic effects of escherichia coli nissle 1917 involve zo-2 and pkczeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007;9:804-816.
110. Mennigen R, et al. Probiotic mixture vsl#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009;296:G1140-G1149.
111. Alberda C, et al. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007;85:816-823.
112. Uronis J, et al. Gut microbial diversity is reduced by the probiotic vsl#3 and correlates with decreased tnbs-induced colitis. Inflamm Bowel Dis 2011;17:289-297.
113. Martin FP, et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008;4:157.
114. Yan F, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an egfr-dependent mechanism. J Clin Invest 2011;121:2242-2253.
115. Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG. Faecal siga secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol 2006;17:134-140.
116. Campeotto F, et al. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory iga. Br J Nutr 2011;22:1-10.
117. Ewaschuk J, Dueleman L. Probiotics and prebiotics in chronic inflammatory bowel disease. World J Gastroenterol 2006; 12:5941-5950.
118. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14.
119. Goodman AL, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 2011;108:6252-6257.